Category Archives: Cell Biology

Georgia Tech faculty member: I didnt think I connected with my students online. They disagreed. – Atlanta Journal Constitution

My students love not knowing me

The view from my virtual classroom is bleak. My desk -- a table salvaged from the basement -- sits in an unused corner of a spare bedroom that looks out over a radiator, a pull-out sofa, and the cats litter box. The curated science-themed bookshelf is behind me, a faade of normalcy. It is from here that I recorded dozens of videos for my cell biology course last semester. I spent my days alone with intracellular signaling pathways, motor proteins, and the cytoskeleton. I spoke to no one but my webcam. Each Sunday I sent the videos into the void and hoped some of the 60 students enrolled in my class would watch them.

Were my students even there?

Before the first exam, I held an online review session. One student showed up, connecting from the lodge at Yellowstone where she was vacationing with her family. She didnt have any questions, but it was raining outside so she decided to log in and meet me. We spoke for about 10 minutes, and she told me she didnt know anyone else in the class. I held other online office hours that no one attended. I held a review session for the final exam, and three people logged on. Within two weeks of the end of the semester, I forgot the names of everyone in the class.

Georgia Tech professor Jennifer Leavey

Credit: Christopher Moore

Credit: Christopher Moore

For me, this unexpectedly online course was a disappointment. This course was supposed to be taught at a study abroad program in Lyon, France, where I have been part of the faculty for five years. Most years, the class is small. We have seminar-style discussions. We take field trips to local tech companies so students have a sense of what research looks like in an industrial setting. I invite groups of students to my rented apartment where we get to know each other over home cooked meals I create with ingredients from the daily fresh market down the street.

We have conversations about the students hopes and dreams, and I help connect them with research advisors who share their interests. On occasion, I write them letters of recommendation for things like medical school or the Fulbright scholars program.

This semester, I didnt get to know anyone.

When my end-of-semester anonymous course evaluations arrived, I clicked the link with dread. Surely this semester would leave a stain, much like the rest of 2020. But as I started to read, it became clear that my students perception of our relationship was very different than my own. One student said, Dr. Leavey was always incredibly helpful when I ran into any issues I really appreciated her concern for us and our well-being! Another said, She respected her students and was very available for help.

Yet another said, She was very accessible and willing to go above and beyond to help students. She was very caring and considerate, especially as these are difficult and uncertain times for us all. How could this be? Somehow, I must have been conveying compassiondigitally.

I looked through my weekly class announcements for signs that I cared. Some of my notes reflected my own fears, like if you are in Georgia be safe out there. COVID-19 is worse now than it ever has been and Please stay safe and protect others by staying socially distant and wearing a mask. Other messages suggested I was available and accessible, and perhaps even desperate to connect: feel free to email me or any the TAs any time and Let me know if you would like to get together and discuss the course (or anything).

While I wasnt hearing from very many students in any given week, they must have been hearing me loud and clear.

Is it possible that remote learning can feel even more personal for the student than in-person instruction does? In a normal semester, I would be at the front of the room. Depending on where my students sit, they may not be able to see or hear me very well. But my remote class was somehow intimate. I was arriving in my students inbox every day. My face was on a screen in their lap. My voice was in their earbuds. The unused corner of my spare bedroom was in their house, no matter where they were in the world. And maybe my students knew me better than they ever have before. If only I knew them.

About the Author

Maureen Downey has written editorials and opinion pieces about local, state and federal education policy since the 1990s.

Go here to read the rest:
Georgia Tech faculty member: I didnt think I connected with my students online. They disagreed. - Atlanta Journal Constitution

Differential Effects of Fingolimod and Natalizumab on B Cell Repertoires in Multiple Sclerosis Patients – DocWire News

This article was originally published here

Neurotherapeutics. 2020 Nov 30. doi: 10.1007/s13311-020-00975-7. Online ahead of print.

ABSTRACT

Natalizumab and fingolimod are effective multiple sclerosis (MS) therapies that disrupt lymphocyte migration but have differential effects on B cell maturation and trafficking. We investigated their effects on peripheral blood (PB) and cerebrospinal fluid (CSF) B cell repertoires using next-generation deep sequencing. Paired CSF and PB B cell subsets (nave, CD27+ memory, and CD27IgD double-negative B cells and plasmablasts) were collected by applying flow cytometry at baseline and after 6 months of treatment and their respective heavy-chain variable region repertoires assessed by Illumina MiSeq. Treatment with fingolimod contracted, whereas natalizumab expanded circulating PB B cells. CSF B cell numbers remained stable following fingolimod treatment but decreased with natalizumab therapy. Clonal overlap between CSF and PB B cells was reduced with natalizumab treatment but remained stable with fingolimod therapy. Lineage analyses of pre- and posttreatment CSF B cell repertoires revealed large, clonally expanded B cell clusters in natalizumab-treated MS patients but no intrathecal clonal expansion following fingolimod therapy. Our findings suggest that natalizumab diminishes the exchange of peripheral and intrathecal B cells without impacting intrathecal clonal expansion. In contrast, fingolimod treatment fails to alter blood-brain barrier B cell exchange but diminishes intrathecal clonal expansion. Sphingosine-1 phosphate receptor inhibition may alter intrathecal B cell biology in MS.

PMID:33258072 | DOI:10.1007/s13311-020-00975-7

Read more here:
Differential Effects of Fingolimod and Natalizumab on B Cell Repertoires in Multiple Sclerosis Patients - DocWire News

Cloud Computing in Cell Biology, Genomics and Drug Development Market Size And Forecast (2020-2026)| With Post Impact Of Covid-19 By Top Leading…

This report studies the Cloud Computing in Cell Biology, Genomics and Drug Development Market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the complete Cloud Computing in Cell Biology, Genomics and Drug Development Market analysis segmented by companies, region, type and applications in the report.

The report offers valuable insight into the Cloud Computing in Cell Biology, Genomics and Drug Development market progress and approaches related to the Cloud Computing in Cell Biology, Genomics and Drug Development market with an analysis of each region. The report goes on to talk about the dominant aspects of the market and examine each segment.

#Key Players: Google Inc.,Amazon Web Services, Inc.,IBM Corp.,Oracle Corporation,Microsoft Corp.,Arisglobal,Benchling,Box Inc,Cisco Systems,Dell Emc,Cognizant,Dincloud,Exponential-e,Informatica.

Get a Free Sample [emailprotected] https://www.reportsandmarkets.com/sample-request/covid-19-impact-on-global-cloud-computing-in-cell-biology-genomics-and-drug-development-market-report-history-and-forecast-2015-2026-breakdown-data-by-companies-key-regions-types-and-application?utm_source=khabarsouthasia&utm_medium=14

The global Cloud Computing in Cell Biology, Genomics and Drug Development market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cloud Computing in Cell Biology, Genomics and Drug Development market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2020-2026.

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Research objectives:

To study and analyze the global Cloud Computing in Cell Biology, Genomics and Drug Development market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2026.

To understand the structure of Cloud Computing in Cell Biology, Genomics and Drug Development market by identifying its various sub segments.

Focuses on the key global Cloud Computing in Cell Biology, Genomics and Drug Development players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Cloud Computing in Cell Biology, Genomics and Drug Development with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the size of Cloud Computing in Cell Biology, Genomics and Drug Development submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.

Table of Contents: Cloud Computing in Cell Biology, Genomics and Drug Development Market

Key questions answered in this report

Get complete Report @ https://www.reportsandmarkets.com/sample-request/covid-19-impact-on-global-cloud-computing-in-cell-biology-genomics-and-drug-development-market-report-history-and-forecast-2015-2026-breakdown-data-by-companies-key-regions-types-and-application?utm_source=khabarsouthasia&utm_medium=14

About Us:

Reports and Markets is not just another company in this domain but is a part of a veteran group called Algoro Research Consultants Pvt. Ltd. It offers premium progressive statistical surveying, market research reports, analysis & forecast data for a wide range of sectors both for the government and private agencies all across the world. The database of the company is updated on a daily basis. Our database contains a variety of industry verticals that include: Food Beverage, Automotive, Chemicals and Energy, IT & Telecom, Consumer, Healthcare, and many more. Each and every report goes through the appropriate research methodology, Checked from the professionals and analysts.

Contact Us:

Sanjay Jain

Manager Partner Relations & International Marketing

http://www.reportsandmarkets.com

Ph: +1-352-353-0818 (US)

Continue reading here:
Cloud Computing in Cell Biology, Genomics and Drug Development Market Size And Forecast (2020-2026)| With Post Impact Of Covid-19 By Top Leading...

Stem Cell Medical Research to Expand in California Following Passage of Prop. 14 – Times of San Diego

Share This Article:A stem cell research center at UC Davis. Courtesy California Institute for Regenerative MedicineBy Barbara Feder Ostrov | CalMatters

Californias stem cell research agency was supposed to be winding down its operations right about now, after a 16-year run and hundreds of millions in grants to scientists researching cutting-edge treatments for diabetes, cancer, Alzheimers and other diseases.

Support Times of San Diego's growthwith a small monthly contribution

Instead, the taxpayer-supported California Institute for Regenerative Medicine will get a $5.5 billion reboot after voters earlier this month narrowly passed the Proposition 14bond measure. The overall cost of the bonds with interest will total about $7.8 billion.

Were thrilled that California voters saw fit to continue the work weve done, said Jonathan Thomas, chair of the agencys governing board. California has always had a frontier mentality and a love for the cutting edge, and the work that CIRM has done has put it on the very forefront of regenerative medicine.

Even with Californias economy in a coronavirus-induced tailspin and somescientists arguingthat stem cell research no longer needs taxpayer support,Prop. 14passed with 51 percent of the vote after well-financed supporters pourednearly $21 millioninto the Yes on 14 campaign. The measure was essentially a rerun of Proposition 71, which California voters approved in 2004 after a since-revoked federal ban on embryonic stem cell research.

The cash infusion is expected to keep the institute running for another 10 to 15 years, although the agency will see some significant changes under Prop. 14.

The institute also must contend with longstanding concerns over conflicts of interest that have dogged it since its inception, observers say. About 80% of the money distributed has gone to universities and companies tied to agency board members, according to an analysisby longtime agency watchdog David Jensen, a former Sacramento Bee journalist who runs theCalifornia Stem Cell Reportblog and wrote abookon the institute.

Prop. 14 allows the agency to fund a wider array of research projects even some that dont involve stem cells, but instead are related to genetics, personalized medicine and aging.

Thats necessary because the field has evolved, said Paul Knoepfler, a UC Davis professor of cell biology who studies the role of stem cells in cancer and writes a stem cell blog. He received a 2009 grant from the institute.

Stem cells are interesting and important, but there are going to be a lot of new therapies in the next 10 years that are not stem-cell centric, Knoepfler said.

Other changes for the agency include:

Ysabel Duron, who joined the institutes board late last year, said she sees her role as promoting equity in opportunities for both researchers and patients and ensuring that treatments resulting from the research can benefit all Californians.

Researchers in particular need to boost the diversity of patients in their clinical trials and do a better job communicating the value of their work to the public, Duron said, noting that nearly 40% of Californians are Latino.

We need to keep researchers feet to the fire, said Duron, a former television journalist and founder of the Latino Cancer Institute. They need to show us a plan and we need to reward them.

To date, the agency has funded 64 clinical trials of treatments for many types of cancer, sickle cell disease, spinal cord injuries, diabetes, kidney disease and amyotrophic lateral sclerosis, commonlyknown as Lou Gehrigs disease.But the most advanced trials involve therapies for relatively rare conditions, such asSevere Combined Immunodeficiency known as the bubble baby disease, Jensen noted. That therapy is being reviewed by the FDA but has not yet been approved.

Cancer, heart disease these are the big killers. Thats what most people are interested in, Jensen said. You can fund something for a rare disease, but that doesnt affect the majority of Californians.

And, Jensen asks, what will happen after the agency runs out of money again? Will taxpayers once again be asked to refill its coffers? There was hope when the agency began that revenues from successful treatments would sustain its grant-making in the years to come, but the institute has only received a few hundred thousand dollars, not nearly enough to become self-sustaining without taxpayer support, according to theLegislative Analysts Office.

The sustainability issue is important and its hard to address, Jensen said. The money doesnt last forever.

CalMatters is a public interest journalism venture committed to explaining how Californias state Capitol works and why it matters.

Stem Cell Medical Research to Expand in California Following Passage of Prop. 14 was last modified: November 28th, 2020 by Editor

>> Subscribe to Times of San Diegos free daily email newsletter! Click here

Follow this link:
Stem Cell Medical Research to Expand in California Following Passage of Prop. 14 - Times of San Diego

Inflammation produced by bacterial infection ‘alerts’ the brain stem cells – News-Medical.net

The study, directed by Isabel Farias and published in the November digital edition of the journal Cell Stem Cell, reveals that the inflammation produced by a bacterial infection 'alerts' the brain stem cells and prepares their activation for the production of new neurons. The study represents a new advance in the field of regenerative medicine.

The team of researchers from the Molecular Neurobiology group of the University of Valencia, led by the professor of Cell Biology Isabel Farias, has just published in the journal Cell Stem Cell the results of a work that sheds light on the role of inflammation in the normal programming of adult brain stem cell activation to produce new neurons throughout life.

Our tissues are constantly renewed thanks to stem cells, which generate new specialized cells to replace those that are lost through "wear and tear". These stem cells are located in very specific locations within tissues, which are known as microenvironments or niches, and in which stem cells interact with other types of cells.

The new findings indicate that brain stem cells also respond to changes that occur outside the brain. This study, carried out in mice, has verified that the inflammation produced by a bacterial infection in any part of the body is capable of temporarily activating brain stem cells and preparing them for action. When the inflammation subsides, these cells return to their quiescent state.

The work allows us to better understand the relationships between stem cells and the systemic environment, that is, the rest of the organism, as knowledge on the subject is very limited. We are used to stem cells responding to their closest microenvironment, but evidence is beginning to emerge showing that they can respond to what is happening in any part of the body thanks to molecules that are distributed through the circulatory system."

Isabel Farias, Professor of Cell Biology, University of Valencia

The work of the research team contributes, once again, new data to the study and advancement of regenerative medicine, a field of science that seeks therapeutic solutions based on stem cells for degenerative processes, such as Alzheimer's or Parkinson's diseases in which neuroinflammation is usually detected.

"We have always been more concerned about chronic inflammation that is associated with many diseases and is very negative for our organs, but it is a defence mechanism against damage or infection", explains Jos Manuel Morante, co-director of the work. "For this reason, it is important to find out the role of inflammation in the regulation of stem cells", he concludes.

Several doctors from the University of Valencia (Germn Belenguer, Ana Domingo, Toni Jordn, Sacri R. Ferrn and Jos Manuel Morante) and researchers in training Pere Duart and Laura Blasco have participated in the research. Farias' team belongs to the Molecular Neurobiology group of the Institute of Biotechnology and Biomedicine of the same University, the Centre for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED) and the RETIC of Cell Therapy of the Carlos III Health Institute, and is a Prometheus group of excellence of the Valencian Government.

Source:

Journal reference:

Belenguer, G., et al. (2020) Adult Neural Stem Cells Are Alerted by Systemic Inflammation through TNF- Receptor Signaling. Cell Stem Cell. doi.org/10.1016/j.stem.2020.10.016.

Go here to see the original:
Inflammation produced by bacterial infection 'alerts' the brain stem cells - News-Medical.net

MTSU researcher-led study: Instructors need to address compatibility of religion, science while teaching evolution – Newswise

Newswise MURFREESBORO, Tenn. A first-of-its-kind study led by Middle Tennessee State University biology researcher Elizabeth Barnes suggests that a difference in culture and beliefs between science instructors and students may inadvertently lead to low acceptance of evolution among minority students particularly Black students in biology.

Barnes and Arizona State University researchers asked whether Black and Hispanic students tended to reject evolution more than students from other racial/ethnic identities and whether any differences could be explained by the fact they tend to be more religious.

The study, published Friday, Nov. 20, by CBE Life Sciences Educations quarterly journal, can be found here.

Christianity is popular among 65% of college biology students, but not among the biologists (25%) who are teaching students, which helped the research group understand the motivation for the study.

Further, when looking at students from minority populations, the gap between biologists and student religious affiliation is even wider Black students tend to have stronger religious cultures and backgrounds compared to majority populations.

Researchers found that rejection of evolution was particularly high for Black students, but once they controlled for religious background in their statistical models, the differences between Black and white students were diminished.

This is a concerning finding for STEM (science, technology, engineering and math) educators because Black students are already minoritized in biology and they are particularly absent in fields that emphasize evolution such as ecology and evolutionary biology, said Barnes, who joined the MTSU faculty in August. Our study starts to offer some explanation for why.

Researchers suggest that a solution is to use instructional techniques that highlight the compatibility between religion and evolution rather than where they might conflict.

Science instructors who are often secular themselves are hesitant to address religion and when they do it is often in a way that highlights conflict between religion and science and not compatibility, Barnes said.

To promote an equitable and comfortable STEM environment for religious students, science instructors should more often highlight views such as theistic evolution, for which student can both believe in God and recognize evolution as credible science, she added.

Barnes was joined in the research by K. Supriya, Hayley M. Dunlop, Taija M. Hendrix, Gale M. Sinatra and Sara E. Brownell. They began collecting data five years ago.

We collected a lot of data and spent a lot of time revising the work based on feedback and reading about the experiences of Black and Hispanic individuals, Barnes said.

Barnes labs website can be found here.

CBE Life Sciences Education is a free, online quarterly journal published by the American Society of Cell Biology. It publishes peer-reviewed articles on life science education at the K-12, undergraduate and graduate levels.

About Liz Barnes

Assistant professor Elizabeth Barnesis an MTSU science education researcher. She studies the intersections of science and religion, how individuals perceive the relationship between science and religion and how science educators can foster productive conversations with communities and students of faith to promote science education.

Coming from Arizona State University, where she earned bachelors, masters and doctoral degrees, and was a National Science Foundation Graduate Research Fellow, Barnes arrived with grants to continue her research at MTSU.

I came to MTSU to study how to effectively teach controversial topics in biology to students across different religious and political spectrums, she said. I was lured to MTSU because of the Mathematics and Science Education Ph.D. program, which will allow me to mentor graduate students and build a robust research program.

On deck: My past and current research focus is on perceptions of evolution and I have studied how to make evolution education more inclusive for students from different religious and racial/ethnic backgrounds, she said. I am now excited to be embarking on projects exploring perceptions of climate change, vaccines and COVID19.

Originally posted here:
MTSU researcher-led study: Instructors need to address compatibility of religion, science while teaching evolution - Newswise

Researcher Examining CBD Effects on Metabolic Syndrome | Newsroom – UC Merced University News

About 35 percent of Americans have metabolic syndrome, a group of risk factors that raises the risk of cardiovascular disease the leading cause of death in the United States.

If you have three of these five issues, you have metabolic syndrome, according to the American Heart Association:

Department of Molecular and Cell Biology Chair and Health Sciences Research Institute memberProfessor Rudy Ortiz is launching a new project to find out if cannabidiol (CBD), either derived from hemp or synthesized in the lab, can have positive effects on issues within metabolic syndrome.

Ortiz will receive $300,000 over the next two years from the Center for Medical Cannabis Research (CMCR) at UC San Diego to see whether CBD can ameliorate hypertension and glucose intolerance in models of metabolic syndrome.

There have been two different studies showing two different results, so we dont know what the truth is, Ortiz said. No study has looked at this directly in a controlled setting, so our data is applicable no matter what it shows.

Professor Anna Song, director of the Nicotine and Cannabis Policy Center at UC Merced, agreed.

Professor Ortizs study will be an important contribution. Our communities are barraged with messages regarding the benefits of CBD and cannabis, but the science isnt just there yet, Song said. This study will be extremely helpful in shedding some light on where CBD is helpful and where it might not help at all.

This pilot study is one important step on the path to human trials if the results are positive.

We need to keep our minds open about what plant-based compounds of any kind can offer, Ortiz said. There has been so much stigma around cannabis, but its becoming more accepted, especially its medicinal benefits.

Heart disease and Type 2 diabetes are primary outcomes of metabolic syndrome, and high blood pressure can lead to stroke, heart attack, vision loss and kidney disease.

Professor Ortizs work exemplifies UC Merceds leadership in using science to explore creative solutions to medical problems that affect millions of Americans, School of Natural Sciences Dean Betsy Dumont said. The potential of this work to identify effective, low-cost treatments that could be made widely available is exciting.

Go here to read the rest:
Researcher Examining CBD Effects on Metabolic Syndrome | Newsroom - UC Merced University News

Government of Canada and JDRF Canada announce new research funding to accelerate stem cell-based therapies for type 1 diabetes – India Education Diary

Ottawa: There are more than 300,000 Canadians living with type 1 diabetes (T1D), an autoimmune disease with no known cause or cure, resulting in the dysfunction, damage or loss of pancreatic beta cells that produce insulin in our bodies. People with T1D must treat themselves with insulin several times per day to keep their blood glucose levels normal, and despite their best efforts, they often experience serious, and even life-threatening, complications.

To mark the end of Diabetes Awareness Month, Sonia Sidhu, Member of Parliament for Brampton South, on behalf of the Honourable Patty Hajdu, Minister of Health, announced an investment of $6 million through the CIHR-JDRF Partnership to Defeat Diabetes for two Canadian research teams to accelerate the development of stem cell-based therapies for the treatment of T1D.

Stem cells show great promise as a source of insulin-producing cells that could be transplanted to provide a new source of insulin, to replace dysfunctional, damaged or lost pancreatic beta cells. Canada has a remarkable legacy in leading discoveries in this area. Stem cells were discovered in Toronto in 1961, and in 2000, a team in Edmonton were the first to pioneer transplantation of pancreatic islets (the part of the pancreas that contains insulin-producing cells). These achievements represent important steps toward a treatment that will allow people with T1D to live healthy lives without daily insulin injections.

The research teams are led by Dr. Maria Cristina Nostro at the University Health Network and the University of Toronto and Dr. Francis Lynn at the BC Childrens Hospital Research Institute and the University of British Columbia. The teams will build on Canadas demonstrated research excellence and leadership in clinical islet transplantation, stem cell biology, diabetes, immunology and genetic engineering to accelerate stem cell-based therapies for T1D. They will work in collaboration with other Canadian researchers to tackle some of the biggest scientific challenges that impede our progress in this area and move us closer to a future where people with T1D will no longer rely on insulin therapy.

This funding was provided by the Canadian Institutes of Health Research Institute of Nutrition, Metabolism and Diabetes (CIHR-INMD), and JDRF Canada, through the CIHR-JDRF Partnership to Defeat Diabetes established in 2017. Each partner will invest $3 million over five years. This investment is part of a large research initiative, 100 Years of Insulin: Accelerating Canadian Discoveries to Defeat Diabetes, funded by CIHR and partners. This initiative commemorates the 100th anniversary of the discovery of insulin to be marked in 2021a discovery that changed the lives of millions of Canadians and people around the world and won researchers Sir Frederick Banting and John Macleod the Nobel Prize in Physiology or Medicine.

More here:
Government of Canada and JDRF Canada announce new research funding to accelerate stem cell-based therapies for type 1 diabetes - India Education Diary

Biology Textbooks Wrong? New Research Reveals the Secret Behind a Key Cellular Process – SciTechDaily

For the first time, researchers describe how Rho protein really stops gene expression.

New research has identified and described a cellular process that, despite what textbooks say, has remained elusive to scientists until now precisely how the copying of genetic material that, once started, is properly turned off.

The finding concerns a key process essential to life: the transcription phase of gene expression, which enables cells to live and do their jobs.

During transcription, an enzyme called RNA polymerase wraps itself around the double helix of DNA, using one strand to match nucleotides to make a copy of genetic material resulting in a newly synthesized strand of RNA that breaks off when transcription is complete. That RNA enables production of proteins, which are essential to all life and perform most of the work inside cells.

Just as with any coherent message, RNA needs to start and stop in the right place to make sense. A bacterial protein called Rho was discovered more than 50 years ago because of its ability to stop, or terminate, transcription. In every textbook, Rho is used as a model terminator that, using its very strong motor force, binds to the RNA and pulls it out of RNA polymerase. But a closer look by these scientists showed that Rho wouldnt be able to find the RNAs it needs to release using the textbook mechanism.

We started studying Rho, and realized it cannot possibly work in ways people tell us it works, said Irina Artsimovitch, co-lead author of the study and professor of microbiology at The Ohio State University.

The research, published online by the journalScience today, November 26, 2020, determined that instead of attaching to a specific piece of RNA near the end of transcription and helping it unwind from DNA, Rho actually hitchhikes on RNA polymerase for the duration of transcription. Rho cooperates with other proteins to eventually coax the enzyme through a series of structural changes that end with an inactive state enabling release of the RNA.

The team used sophisticated microscopes to reveal how Rho acts on a complete transcription complex composed of RNA polymerase and two accessory proteins that travel with it throughout transcription.

This is the first structure of a termination complex in any system, and was supposed to be impossible to obtain because it falls apart too quickly, Artsimovitch said.

It answers a fundamental question transcription is fundamental to life, but if it were not controlled, nothing would work. RNA polymerase by itself has to be completely neutral. It has to be able to make any RNA, including those that are damaged or could harm the cell. While traveling with RNA polymerase, Rho can tell if the synthesized RNA is worth making and if not, Rho releases it.

Artsimovitch has made many important discoveries about how RNA polymerase so successfully completes transcription. She didnt set out to counter years of understanding about Rhos role in termination until an undergraduate student in her lab identified surprising mutations in Rho while working on a genetics project.

Rho is known to silence the expression of virulence genes in bacteria, essentially keeping them dormant until theyre needed to cause infection. But these genes do not have any RNA sequences that Rho is known to preferentially bind. Because of that, Artsimovitch said, it has never made sense that Rho looks only for specific RNA sequences, without even knowing if they are still attached to RNA polymerase.

In fact, the scientific understanding of the Rho mechanism was established using simplified biochemical experiments that frequently left out RNA polymerase in essence, defining how a process ends without factoring in the process itself.

In this work, the researchers used cryo-electron microscopy to capture images of RNA polymerase operating on a DNA template in Escherichia coli, their model system. This high-resolution visualization, combined with high-end computation, made accurate modeling of transcription termination possible.

RNA polymerase moves along, matching hundreds of thousands of nucleotides in bacteria. The complex is extremely stable because it has to be if the RNA is released, it is lost, Artsimovitch said. Yet Rho is able to make the complex fall apart in a matter of minutes, if not seconds. You can look at it, but you cant get a stable complex to analyze.

Using a clever method to trap complexes just before they fall apart enabled the scientists to visualize seven complexes that represent sequential steps in the termination pathway, starting from Rhos engagement with RNA polymerase and ending with a completely inactive RNA polymerase. The team created models based on what they saw, and then made sure that these models were correct using genetic and biochemical methods.

Though the study was conducted in bacteria, Artsimovitch said this termination process is likely to occur in other forms of life.

It appears to be common, she said. In general, cells use similar working mechanisms from a common ancestor. They all learned the same tricks as long as these tricks were useful.

Reference: 26 November 2020, Science.

Artsimovitch, working with an international research team of collaborators, co-led the study with Markus Wahl, a former Ohio State graduate student now at Freie Universitt Berlin.

This work was supported by grants from the German Research Foundation; the German Federal Ministry of Education and Research; the Indian Council of Medical Research; the Department of Biotechnology, Government of India; the National Institutes of Health; and the Sigrid Juslius Foundation.

More here:
Biology Textbooks Wrong? New Research Reveals the Secret Behind a Key Cellular Process - SciTechDaily

MTSU researcher-led study: Instructors need to address compatibility of religion, science while teaching evolution – Wgnsradio

MTSU science education researcher and biology assistant professor Elizabeth Barnes and five colleagues have published in CBE Life Sciences Educations quarterly journal. The study suggests that a difference in culture and beliefs between science instructors and students may inadvertently lead to low acceptance of evolution among minority students particularly Black students in biology. (MTSU photo by J. Intintoli)

MURFREESBORO, Tenn. A first-of-its-kind study led byMiddle Tennessee State University biologyresearcherElizabeth Barnessuggests that a difference in culture and beliefs between science instructors and students may inadvertently lead to low acceptance of evolution among minority students particularly Black students in biology.

Barnes and Arizona State University researchers asked whether Black and Hispanic students tended to reject evolution more than students from other racial/ethnic identities and whether any differences could be explained by the fact they tend to be more religious.

The study, published Friday, Nov. 20, byCBE Life Sciences Educationsquarterly journal, can be foundhere.

Christianity is popular among 65% of college biology students, but not among the biologists (25%) who are teaching students, which helped the research group understand the motivation for the study.

Further, when looking at students from minority populations, the gap between biologists and student religious affiliation is even wider Black students tend to have stronger religious cultures and backgrounds compared to majority populations.

Researchers found that rejection of evolution was particularly high for Black students, but once they controlled for religious background in their statistical models, the differences between Black and white students were diminished.

This is a concerning finding for STEM (science, technology, engineering and math) educators because Black students are already minoritized in biology and they are particularly absent in fields that emphasize evolution such as ecology and evolutionary biology, said Barnes, who joined the MTSU faculty in August. Our study starts to offer some explanation for why.

Researchers suggest that a solution is to use instructional techniques that highlight the compatibility between religion and evolution rather than where they might conflict.

Science instructors who are often secular themselves are hesitant to address religion and when they do it is often in a way that highlights conflict between religion and science and not compatibility, Barnes said.

To promote an equitable and comfortable STEM environment for religious students, science instructors should more often highlight views such as theistic evolution, for which student can both believe in God and recognize evolution as credible science, she added

Barnes was joined in the research byK. Supriya,Hayley M. Dunlop,Taija M. Hendrix,Gale M. SinatraandSara E. Brownell. They began collecting data five years ago.

We collected a lot of data and spent a lot of time revising the work based on feedback and reading about the experiences of Black and Hispanic individuals, Barnes said.

Barnes labs website can be foundhere.

CBE Life Sciences Education is a free, online quarterly journal published by the American Society of Cell Biology. It publishes peer-reviewed articles on life science education at the K-12, undergraduate and graduate levels.

About Liz Barnes

Assistant professor ElizabethBarnesis an MTSU science education researcher. She studies the intersections of science and religion, how individuals perceive the relationship between science and religion and how science educators can foster productive conversations with communities and students of faith to promote science education.

Coming from Arizona State University, where she earned bachelors, masters and doctoral degrees, and was a National Science Foundation Graduate Research Fellow, Barnes arrived with grants to continue her research at MTSU.

I came to MTSU to study how to effectively teach controversial topics in biology to students across different religious and political spectrums, she said. I was lured to MTSU because of theMathematics and Science Education Ph.D. program, which will allow me to mentor graduate students and build a robust research program.

On deck: My past and current research focus is on perceptions of evolution and I have studied how to make evolution education more inclusive for students from different religious and racial/ethnic backgrounds, she said. I am now excited to be embarking on projects exploring perceptions of climate change, vaccines and COVID19.

Go here to read the rest:
MTSU researcher-led study: Instructors need to address compatibility of religion, science while teaching evolution - Wgnsradio